Human High Temperature Requirement Serine Protease A1 (HTRA1) Degrades Tau Protein Aggregates

Autor(en): Tennstaedt, Annette
Poepsel, Simon
Truebestein, Linda
Hauske, Patrick
Brockmann, Anke
Schmidt, Nina
Irle, Inga
Sacca, Barbara
Niemeyer, Christof M.
Brandt, Roland 
Ksiezak-Reding, Hanna
Tirniceriu, Anca Laura
Egensperger, Rupert
Baldi, Alfonso
Dehmelt, Leif
Kaiser, Markus
Huber, Robert
Clausen, Tim
Ehrmann, Michael
Stichwörter: ALZHEIMER-DISEASE; BETA-STRUCTURE; Biochemistry & Molecular Biology; DEGP; DOMAIN; GENE; IN-VITRO; INDUCED CYTOTOXICITY; PAIRED HELICAL FILAMENTS; PROTEOLYSIS; QUALITY CONTROL
Erscheinungsdatum: 2012
Herausgeber: AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
Journal: JOURNAL OF BIOLOGICAL CHEMISTRY
Volumen: 287
Ausgabe: 25
Startseite: 20931
Seitenende: 20941
Zusammenfassung: 
Protective proteases are key elements of protein quality control pathways that are up-regulated, for example, under various protein folding stresses. These proteases are employed to prevent the accumulation and aggregation of misfolded proteins that can impose severe damage to cells. The high temperature requirement A (HtrA) family of serine proteases has evolved to perform important aspects of ATP-independent protein quality control. So far, however, no HtrA protease is known that degrades protein aggregates. We show here that human HTRA1 degrades aggregated and fibrillar tau, a protein that is critically involved in various neurological disorders. Neuronal cells and patient brains accumulate less tau, neurofibrillary tangles, and neuritic plaques, respectively, when HTRA1 is expressed at elevated levels. Furthermore, HTRA1 mRNA and HTRA1 activity are up-regulated in response to elevated tau concentrations. These data suggest that HTRA1 is performing regulated proteolysis during protein quality control, the implications of which are discussed.
DOI: 10.1074/jbc.M111.316232

Show full item record

Page view(s)

3
Last Week
0
Last month
0
checked on May 20, 2024

Google ScholarTM

Check

Altmetric